Titles
- Dental services and the impact of COVID-19: an analysis of private claims1
- Denture base resins: performance criteria for safety and performance based pathway : guidance for industry and Food and Drug Administration Staff1
- Denver Health: a high-performance public health care system1
- Department of Health and Human Services: Office of Inspector General’s use of agreements to protect the integrity of federal health care programs : report to Congressional requesters1
- Design and use of ANTI-G suits and their activating values in World War II1
- Design considerations and pre-market submission recommendations for interoperable medical devices: guidance for industry and Food and Drug Administration staff1
- Design of public option and capped provider price reforms: important interactions between provider prices and other program features1
- Designing a digital platform to monitor health status and foster trust between patients and clinicians1
- Designing a high-performance health care system for patients with complex needs: ten recommendations for policymakers : expanded and revised edition1
- Designing a statewide health data network: what California can learn from other states1
- Designing advance market commitments for new vaccines1
- Designing the public health system for a healthier U.S1
- Despite documented status, many California immigrants have negative perceptions or experiences of public charge policy1
- Despite gains From ACA, lower rates of health insurance coverage persist among those lacking housing basics1
- Despite insurance, the poorest adults have the worst access to dental care1
- Despite savings on many lab tests in 2019, total Medicare spending increased slightly because of increased utilization for certain high-priced tests1
- Detecting potential overbilling in Medicare reimbursement via hours worked1
- Determining whether to submit an ANDA or a 505(b)(2) application1
- Developing and disseminating a self-sustaining program: the experience of Positive Prevention PLUS1
- Developing and responding to deficiencies in accordance with the least burdensome provisions: guidance for industry and Food and Drug Administration staff1